Ensoma
Clinical trials sponsored by Ensoma, explained in plain language.
-
Gene therapy aims to fix immune system in rare disease
Disease control Recruiting nowThis study tests a one-time gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder that causes severe infections. The treatment uses a modified virus to deliver a working gene to blood stem cells, aiming to restore the ab…
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study probes immune system in rare disease patients
Knowledge-focused Recruiting nowThis study looks at how common certain antibodies and inflammatory markers are in people with chronic granulomatous disease (CGD). Researchers will measure levels of adenovirus-fighting antibodies and inflammatory cytokines in blood samples from 60 adults and children with CGD. T…
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC